In conclusion, understanding the gender-specific disparities, the influence of estrogens, the significance of redox balance, and the role of the TRX2 system in MASLD onset and progression provides valuable insights into the pathophysiology of this complex disorder. This evidence concerns the gene TXN2 and metabolic dysfunction-associated steatotic liver disease.